Q
Quant'AbondanceL'abondance, quantifiée.

Actualités

Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.

24,258 signal articles · 46 in last 24h · 115,243 total before filter · latest 1h ago
46last 24h
1804last 7d
299● bullish (7d)
171● bearish (7d)
205publishers
AllMacro322Earnings851M&A105Regulatory25Product16Analyst25
✕ clear all filtersticker: AXPSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
American Express (AXP) Preferred Offering Puts Its Undervalued Narrative Back In Focus
Simply Wall St.7d agoneutral
American Express (AXP) Preferred Offering Puts Its Undervalued Narrative Back In Focus

American Express (AXP) has drawn fresh attention after completing a US$1.6b fixed income offering of preferred depository shares, giving investors another lens on the company alongside its common stock performance and recent earnings commentary. See our latest analysis for American Express. Against this backdrop, American Express shares trade at US$340.91, with a 90 day share price return of 7.87% even as the year to date share price return is down 8.54%. The 5 year total shareholder return...

TripAdvisor Q2 Earnings Call Highlights
MarketBeat8d agoneutral
TripAdvisor Q2 Earnings Call Highlights

TripAdvisor (NASDAQ:TRIP) reported second-quarter results in line with its expectations as growth in its experiences business was offset by persistent search-related pressure in legacy offerings and uneven travel demand. The company also said it expects to complete the sale of restaurant reservation

SRX Global Acquires Stake in Vistagen Therapeutics
InvestorsHub11d agoneutral
SRX Global Acquires Stake in Vistagen Therapeutics

SRX Global (AMEX:SRXH) disclosed an investment in Vistagen Therapeutics (NASDAQ:VTGN) and said it intends to engage with the company’s leadership and board on potential shareholder value initiatives. Key Investor TakeawaysSRX Global (AMEX:SRXH) acquired a stake in Vistagen Therapeutics (NASDAQ:VTGN).

3 Reasons Investors Watch American Express (AXP)
StockStory11d agoneutral
3 Reasons Investors Watch American Express (AXP)

Since February 2026, American Express has been in a holding pattern, posting a small loss of 3.2% while floating around $338.50. The stock also fell short of the S&P 500’s 8.3% gain during that period.

How Investors Are Reacting To American Express (AXP) Raising 2026 Revenue Outlook While Keeping EPS Steady
Simply Wall St.12d agoneutral
How Investors Are Reacting To American Express (AXP) Raising 2026 Revenue Outlook While Keeping EPS Steady

In July 2026, American Express reported higher second-quarter net income of US$3,110 million and raised its full-year 2026 revenue growth guidance to 10%, while maintaining earnings-per-share guidance at US$17.30 to US$17.90 and completing a share buyback of 74,093,544 shares for US$18.32 billion under its 2023 program. The company’s decision to upgrade revenue expectations while holding EPS guidance steady highlights its choice to reinvest in customer acquisition, technology, and lifestyle...

5 Must-Read Analyst Questions From American Express’s Q2 Earnings Call
StockStory15d agoneutral
5 Must-Read Analyst Questions From American Express’s Q2 Earnings Call

American Express’s results for Q2 were in line with Wall Street’s revenue expectations and slightly exceeded earnings estimates, but the market reacted negatively. Management pointed to strong momentum in premium product adoption, especially the Platinum Card refresh, as a key factor driving double-digit revenue growth. CEO Stephen Squeri highlighted that both new customer acquisition and greater engagement from existing cardholders contributed to the acceleration in spend, particularly in trave

2 Software Stocks to Target This Week and 1 We Question
StockStory15d agoneutral
2 Software Stocks to Target This Week and 1 We Question

From commerce to culture, software is digitizing every aspect of our lives. This secular theme has materialized in superior earnings growth and stock price performance for most SaaS companies, and over the last six months, the industry’s 13.5% return has topped the S&P 500 by 8.6 percentage points.